Edition:
United States

Juniper Pharmaceuticals Inc (JNP.OQ)

JNP.OQ on NASDAQ Stock Exchange Global Select Market

8.40USD
22 Feb 2018
Change (% chg)

-- (--)
Prev Close
$8.40
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
9,015
52-wk High
$8.90
52-wk Low
$3.65

Chart for

About

Juniper Pharmaceuticals, Inc. is a women’s health therapeutics company. The Company is focused on developing therapeutics that address unmet medical needs in women’s health. It operates in two segments: product and service. The product segment is engaged in manufacturing and supplying CRINONE, the Company’s commercialized... (more)

Overall

Beta: 0.59
Market Cap(Mil.): $90.55
Shares Outstanding(Mil.): 10.84
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.22 16.52
EPS (TTM): -- -- --
ROI: -- 14.09 36.19
ROE: -- 15.56 17.38

BRIEF-Juniper Pharmaceuticals To Explore Strategic Alternatives

* JUNIPER PHARMACEUTICALS - ‍ ENGAGED ROTHSCHILD AS ITS INDEPENDENT FINANCIAL ADVISOR TO ASSIST JUNIPER IN EVALUATING POTENTIAL STRATEGIC ALTERNATIVES​ Source text for Eikon: Further company coverage:

Jan 31 2018

BRIEF-Juniper Pharmaceuticals Outlines Strategic Priorities For 2018 And Reports Recent Portfolio Progress

* JUNIPER PHARMACEUTICALS OUTLINES STRATEGIC PRIORITIES FOR 2018 AND REPORTS RECENT PORTFOLIO PROGRESS

Jan 02 2018

BRIEF-Juniper Pharmaceuticals reports third quarter results

* Juniper Pharmaceuticals reports third quarter 2017 financial and operating results

Nov 02 2017

BRIEF-Juniper Pharmaceuticals announces strategic reprioritization

* Juniper Pharmaceuticals announces strategic reprioritization

Sep 18 2017

Competitors

Earnings vs. Estimates